论文部分内容阅读
目的探讨酚妥拉明联合多巴胺治疗肺源性心脏病(简称肺心病)的疗效。方法对照组采用抗生素、支气管扩张剂、止咳祛痰剂、吸氧及少量强心利尿剂等综合治疗。观察组在综合治疗的基础上加用酚妥拉明及多巴胺(5%GNS 250 ml+酚妥拉明10 mg+多巴胺20 mg)静脉滴注,每日1次,连用7~10 d为一疗程。结果显效:观察组12例,对照组4例,两组差异有统计学意义(P<0.01)。有效:观察组15例,对照组8例,两组差异有统计学意义(P<0.05)。无效:观察组5例,对照组16例,两组差异有统计学意义(P<0.01)。结论酚妥拉明联合多巴胺治疗肺心病有效。
Objective To investigate the efficacy of phentolamine combined with dopamine in the treatment of pulmonary heart disease (referred to as pulmonary heart disease). Methods The control group was treated with antibiotics, bronchodilators, cough expectorant, oxygen inhalation and a small amount of cardiac diuretic. The observation group was treated with intravenous drip of phentolamine and dopamine (5% GNS 250 ml + Phentolamine 10 mg + dopamine 20 mg) on the basis of comprehensive treatment once daily for 7 to 10 days. The results were significant: the observation group of 12 cases, 4 cases in the control group, the difference between the two groups was statistically significant (P <0.01). Effective: the observation group of 15 cases, the control group of 8 cases, the difference between the two groups was statistically significant (P <0.05). Invalid: 5 cases in the observation group and 16 cases in the control group, the difference between the two groups was statistically significant (P <0.01). Conclusion Phentolamine combined with dopamine is effective in treating pulmonary heart disease.